Maitreya Medicare Limited · NSE:MAITREYA

Maitreya Medicare — H1 FY2026 Earnings Presentation

27 slides from Maitreya Medicare's earnings presentation, Nov 16, 2025

  1. Slide 1: Cover letter to NSE: Investor Presentation

    rw vy = 2] ad Multi Superspeciality Hospital & Research Centre Healing by Heart 16th November, 2025 To, The Listing Compliance Department National Stock Exchange of India Limited, Exchange Plaza, Plot no. C/I, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai -400051. Sub: Investor Presentation Scrip

  2. Slide 2: Investor Presentation

    Investor NSE - S M : MAITREYA Presentation Maitreya Medicare Limited NOVEMBER 2 0 2 5

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Maitreya Medicare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any sec

  4. Slide 4: Content

    Content R esu lt H ig h lig h ts About Us B u sin ess M o d el Grow th D rivers Fin an c ial P erfo rm an c e Investor Presentation

  5. Slide 5: Result Highlights

    Result Highlights Investor Presentation

  6. Slide 6: Management Comments

    Management Comments It's been almost TWO years since our IPO, an d the journey has been truly remarkable. We have s tarted see in g frui ts fro m our e xpansion thi s y ear. Shree Pranna th H ospital has sta rted co n tr ibutin g in re venues , Cath lab at K LS Me m oria l H o spi tal , M u mbai ha

  7. Slide 7: About Us

    About Us Investor Presentation

  8. Slide 8: Company Overview

    Company Overview Maitreya Medicare is a Multi Super speciality hospital established in 2019 and located in Surat, Gujarat with 125 b ed capacity an d 50 be d capacity in its subsidiary Tulip Health Check. Our facility offers a wide range of integrated healthcare services, spanning primary, secondary

  9. Slide 9: Our Journey

    Our Journey Maitreya Medicare expanded for B Wing a n d converted into 125 Established and beds from 100 beds Received Building Received AERB M O U for Maitreya Usage Permission for its c o m m e n c e d operations Conversion of our registration or its n e w Hospital Private Limited, n e w hospital

  10. Slide 10: Our Services

    Our Services Cardiology Cardiothoracic and Critical Care Medicine Vascular Surgery Orthopedic & Joint Neurology NeuroSurgery Replacement Investor Presentation Surgery

  11. Slide 11: Our Services

    Our Services Gastroenterology General & Urology Gynecology & High Laparoscopic Surgery Risk Obstetrics Nephrology Oncology Oncosurgery Emergency & Trauma Investor Presentation

  12. Slide 12: Management

    Management Dr. Narendra Singh Tanwar Dr. Pranav Thaker Mr. Vimalkumar Patel Chairman, Managing Director and CFO Whole Time Director Whole Time Director Dr. Narendra Singh Tanwar is a leading expert in Dr. Pranav is a prom i nent figure in the Mr. Vi m a l has been wi th the com pa ny since its the f

  13. Slide 13: Business Model

    Business Model Investor Presentation

  14. Slide 14: Hospital Portfolio

    Hospital Portfolio Maitreya Medicare Limited Maitreya Life science Private Limited (Holding Company) (Subsidiary) Surat, Gujarat Surat, Gujarat Established 2019 Established 2020 125 B ed Capacity Cardiology Department Maitreya Medicare Limited is Flagship Maitreya has Cardiology departm ent wi t h C

  15. Slide 15: Hospital Portfolio

    Hospital Portfolio Tulip Health Check Maitreya Hospital Private KLS Memorial Hospital (Subsidiary) Limited (Subsidiary) (Operational Partner) Surat, Gujarat Valsad, Gujarat Mum bai, Maharashtra Partnered in 2023 U p c o m i n g in 2024 Partnered in 2024 50 B e d Capacity 125 B e d Capacity 70 B e d

  16. Slide 16: Hospital Portfolio

    Hospital Portfolio Prannath Hospital Surat, Gujarat Partnered in 2024 100 B e d Capacity Intervention Cardiology / Cardiothoracic Surgery, Intervention Radiology, Critical Care, including E C M O and CRRT, M edical a nd Surgical Oncology, offering the latest chemotherapy treatments a n d organ/funct

  17. Slide 17: Growth Drivers

    Growth Drivers Investor Presentation

  18. Slide 18: Capacity Expansion

    Capacity Expansion Our strategy focuses on expanding our healthcare services across the Gujarat and Maharashtra region by strategically locating hospitals in multiple cities and towns. By establishing a presence in various geographic locations, w e a i m to ensure that our services are accessible to

  19. Slide 19: Partnered with KLS Memorial Hospital

    Partnered with KLS Memorial Hospital We have entered into an Operation and Management Service Agreement with KLS Memorial Hospital, a Partnership firm, situated at Vile Parle West, Mumbai, Maharashtra, to render operational and managem e n t services, nursing and quality managem en t services, Plann

  20. Slide 20: Introducing Maitreya at Valsad

    Introducing Maitreya at Valsad Recently w e received Building Usage Permission for our n e w hospital to be established at Valsad, Gujarat. Our initial plan involves commencing operations with 125 beds, aiming to achieve an Average Revenue Per Occupied Bed comparable to that of our Surat unit. We an

  21. Slide 21: Introducing Tulip Health Check

    Introducing Tulip Health Check Established in April 2022 Our initial plan involves Foun de d by Emi ne nt Medical commencing with 50 beds an d Social personnels of South and we anticipate to keep Gujarat. enhancing bed capacity. High end Health Check in One of the Promotes Our Heritage Family Bigges

  22. Slide 22: Segmental Services in High Demand

    Segmental Services in High Demand Segments contribute 60-70% to Revenue Maitreya’s cardiology department Maitreya provides top-notch Maitreya boasts expert Maitreya features expert is renowned for its fully-equipped neuro-intensive care, led by neurosurgeons Intensivists and skilled facilities and s

  23. Slide 23: Industry Growth

    Industry Growth The Indian healthcare sector is expected to The health segment has a 33.33% share in The hospital industry is set to reach Rs. 8.6 record a three- fold rise, growing at a CAG R the total gross written p re m i um s earned in trillion by FY22, growing from Rs. 4 trillion in of 22% bet

  24. Slide 24: Financial Performance

    Financial Performance Investor Presentation

  25. Slide 25: Consolidated Performance

    Consolidated Performance

  26. Slide 26: Consolidated Performance

    Consolidated Performance Details Till Sept 2025 (HA1) Revenue 23.92 Cr EBITDA Loss 0.0360 Cr

  27. Slide 27: Thank You

    Maitreya Medicare Limited www.maitreyahospitals.com THANK YOU Investor Presentation

Maitreya Medicare — H1 FY2026 Earnings Presentation on 6ix